Guangdong VTR Bio-Tech's (SHE:300381) unit, Hunan Kangjie Biotechnology, agreed to sell equipment to Huasai Biotechnology (Changde) for 35.8 million yuan, according to a Shenzhen Stock Exchange disclosure on Tuesday.
The transferred equipment included 44 types of exclusive equipment, such as flat-plate scraper unloading automatic centrifuge and steel-lined PE ion exchange column diaphragm filter press, the Chinese manufacturer of feed additives and veterinary medicine powder said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.